FDA approves Bristol-Myers drug combination for skin cancer

October 1, 2015 11:19 AM

23 0

Drugmaker Bristol-Myers Squibb Co said its combination of two drugs to treat a form of skin cancer was approved by the U.S. Food and Drug Administration.

The company said on Thursday that the approval was based on a late-stage study that showed the two drugs, Opdivo and Yervoy, were more effective than Yervoy alone.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page